Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery

• Status: Recruiting
• Trial end date: 2021-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of the study is to demonstrate the efficacy of Dexmedetomidine on the prolongation of analgesia obtained by interscalenic bloc of the brachial plexus and intravenous injection of Dexamethasone (efficacy objective).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche; GCS Ramsay Santé pour l’Enseignement et la Recherche
• Collaborator: Euraxi Pharma
• Treatments: Anesthetics; Dexamethasone; Dexmedetomidine; Ropivacaine

Criteria

Inclusion Criteria:

• Age ≥ 18 years;

• Patient undergoing arthroscopic shoulder surgery to repair the rotator cuff tendons;

• Patient capable of understanding the information related to the study, of reading the information leaflet and agreeing to sign the consent form.

Exclusion Criteria:

• Patient on oral morphines before surgery;

• Contraindication to performing a general anesthesia associated with a shoulder loco regional anesthesia in a single injection;

• Contraindication to take oral morphines;

• Any non-arthroscopic repair (intraoperative conversion to "open sky" technique);

• Any other loco regional anesthesia than an interscalenic block (change of intraoperative strategy);

• Pregnant or lactating woman;

• Intolerance or allergy or contraindication to one of the treatments under study;

• Patient participating in another clinical trial, or in a period of exclusion from another clinical trial.